CN1120014C - 一种治疗骨质增生的中成药 - Google Patents
一种治疗骨质增生的中成药 Download PDFInfo
- Publication number
- CN1120014C CN1120014C CN01141086A CN01141086A CN1120014C CN 1120014 C CN1120014 C CN 1120014C CN 01141086 A CN01141086 A CN 01141086A CN 01141086 A CN01141086 A CN 01141086A CN 1120014 C CN1120014 C CN 1120014C
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- chinese patent
- patent medicine
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 61
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims description 12
- 235000013372 meat Nutrition 0.000 claims description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 claims description 8
- 241000533849 Gleditsia Species 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 239000000843 powder Substances 0.000 abstract description 4
- 206010030113 Oedema Diseases 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000227129 Aconitum Species 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 208000008558 Osteophyte Diseases 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 201000010934 exostosis Diseases 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010019909 Hernia Diseases 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 206010002027 Amyotrophy Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000000459 calcaneus Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 210000002310 elbow joint Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 241001459693 Dipterocarpus zeylanicus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗骨质增生的外用散剂中成药,其特征是采用麝香、冰片、伸筋草、透骨草、夏枯草、风仙草、生川乌、生草乌、芒硝、乌梅肉、生山楂肉、皂角刺、乳香、没药等14味中草药配制成外用散剂中成药,具有温通经络、活血化瘀、软化骨刺、消肿止痛的功效,符合本病的发病机理。本发明使用时安全可靠,药力持久,临床有效率可达95.9%,是一种值得推广的中成药。
Description
一、技术领域
本发明涉及一种治疗骨质增生的药物,具体地说涉及一种治疗骨质增生的外用中成药。
二、背景技术
骨质增生是一种常见病,俗称“骨刺”,属中医“骨痹”的范畴,主要症状是患病部位活动明显受限,动则疼痛加重,有时肌肉明显痉挛萎缩,晨起或气候潮湿、寒冷时病情加重,颈椎病患者有时还伴有头痛、头晕、视物模糊、四肢麻木等症状,严重者活动能力大大减退,出现肌肉萎缩及体位性眩晕等,从而严重影响了患者的工作、学习和生活,有的甚至丧失了劳动能力。
西医对本病无特效疗法,除对严重患者用手术外,一般用理疗及电离子导入,对颈椎增生患者则用牵引疗法,其疗效不确切,易复发。中医对此病也有很多治疗方法,各有千秋,但疗效均不是令人很满意。
三、发明内容
本发明的目的是提供一种药力强、有效率高并且无毒副作用的治疗骨质增生的中成药。
实现上述目的的解决方案是基于祖国医学对骨质增生发病机理的认识及治疗原则,又经过多年临床研究,吸取古今医家治疗骨质增生的经验,从祖国医药宝库中,筛选出温通经络、活血化瘀、软化骨刺、消肿止痛的中草药,按中医组方理论,提取精华,制备成外用中成药。
中医称骨质增生为“痹证”,发病部位涉及颈椎、腰椎、肘关节、膝关节、跟骨等,虽然其发病部位不同,但其病因有共性,均由于风、寒、湿所致。本发明以“温通经络、活血化瘀、软化骨刺、消肿止痛”为组方依据,符合本病的发病机理。
本发明中成药的中药原料及重量配比为:
麝 香0.3-1份 冰 片3-5份 伸筋草3-5份
透骨草3-5份 夏枯草3-5份 风仙草3-5份
生川乌2-4份 生草乌2-4份 芒 硝3-15份
乌梅肉5-10份 生山楂肉5-10份 皂角刺3-5份
乳 香3-5份 没 药3-10份
将上述重量配比的中药原料制成外用散剂中成药。
本发明中成药中药原料的最佳重量配比是:
麝 香0.6份 冰 片4份 伸筋草4份
透骨草4份 夏枯草4份 风仙草4份
生川乌3份 生草乌3份 芒 硝9份
乌梅肉8份 生山楂肉8份 皂角刺4份
乳 香4份 没 药7份
药理分析:
麝香、冰片活血通络,消肿止痛,取其味香芳烈,通关利窍之上品麝香为首,引药入经,统领诸药,斩关本门,直抵病位;伸筋草、透骨草、风仙草、夏枯草祛风除湿,舒筋活络,活血止痛;生川乌、生草乌、芒硝祛风湿,温经止痛;乌梅肉、生山楂肉、皂角刺行气散结,软坚止痛,降低血糖;乳香、没药活血化瘀,消肿止痛。
上述各药合而用之,共奏“温通经络、活血化瘀、软化骨刺、消肿止痛”之功。
药物炮制:
将上述药物分别炮炼、浓缩、加工细研,混合均匀,分装袋备用。
使用方法:
每袋药粉为一周量,取生铁屑一斤,陈醋一斤,将铁屑与药物各取一半,加老陈醋四勺调匀(以能把布沾湿为度,不可过多,以免失效),用黑粗布做一口袋,长约15cm,宽约10cm,将调好的的药泥装入袋内,敷于患部即可。夜间临睡时敷,晨起床后取下密封。第二天再把袋内药倒出捣碎加四勺醋装入袋内继续敷用,连用三天即可,剩余的药粉和铁屑再连用三天即可。一月为一疗程,一般病例一个疗程症状即可缓解或完全消失。三个疗程便可恢复正常。
本药主治骨质增生症、椎间盘突出、强直性脊柱炎、风湿病等。
外敷疗法在我国已有悠久的历史。早在清代著名医学家徐大椿赞扬膏、散药说:“若其病既有定所,在皮肤筋骨之间可按而得者,用膏、散药贴之,闭塞其气,使药性从毛孔而入腠里,通经贯络或提力出之,较服药尤有力”。当药散被封闭于病变部位时,即产生热气,使药性从局部皮肤毛孔或穴位直接渗入腠里,贯通经络血脉。由于药散贴敷时间长,放药性持续亦久,从而起到了通经络、行气血、濡筋骨的作用。用西医的话说,药散外敷可使局部血管扩张,促进了增生部位的血液及淋巴循环,改善了局部骨组织的营养状态,使肌肉萎缩得到了改善,解除了软组织的痉挛、粘连、肿胀,加速了炎症、水肿和病变产物的吸收,促进了被损害组织的修复。通过对各部位骨质增生症、椎间盘突出、强直性脊柱炎、风湿病的临床观察,外敷本药散在一定程度上修复了磨损的关节软骨面,使变形的骨质趋于正常,使骨刺萎缩变短,使椎间盘突出形成的瘀血、水肿、炎症和被压迫的神经得到缓解,肌肉韧带紧张状态得到松弛,从而使椎间盘自然回缩,达到了较好的解痉止痛的作用,大大缓解了骨刺、椎间盘突出、强直性脊柱炎、风湿病所造成的局部疼痛,活动受限,变形关节的功能活动恢复正常,达到治愈的目的。
下面是用本发明中成药对150例骨质增生患者进行治疗的临床疗效统计。
疗效标准:
痊愈:(1)临床症状消失;
(2)关节功能恢复;
(3)X线复查增生萎缩消失或变细变小。
好转:(1)临床症状减轻;
(2)关节功能部分恢复,能从事轻体力劳动;
(3)X线复查,无明显变化。
无效:临床用药三周,症状、体征、X线复查如故。
治疗结果:
| 病变部位 | 病例数 | 痊愈 | 好转 | 无效 | |||
| 例数 | % | 例数 | % | 例数 | % | ||
| 颈椎 | 29 | 26 | 89.8 | 2 | 7 | 1 | 3.15 |
| 腰椎 | 41 | 31 | 75.6 | 8 | 19.5 | 2 | 4.9 |
| 跟骨 | 45 | 39 | 86.6 | 4 | 11.1 | 2 | 2.3 |
| 肘关节 | 9 | 7 | 77.7 | 2 | 22.3 | / | / |
| 膝关节 | 26 | 22 | 84.6 | 3 | 11.5 | 1 | 3.9 |
| 合 计 | 150 | 125 | 83.3 | 19 | 12.6 | 6 | 4.1 |
由以上统计可知,上述150例骨质增生患者用本发明药散外敷治疗后总有效率为95.9%。
本发明药散临床使用结果表明,有下述优点:
骨刺症、椎间盘突出、强直性脊柱炎、风湿病属中医本虚标实,本发明药散外敷既可益肾治本,亦可温经通络,活血化瘀,软化骨刺,祛风散寒,扶正祛邪,标本同治,充分体现了中医辩证施治的特长,外敷药散治疗方便,易于接受,疗效显著。
四、具体实施方式
实施例1,本发明中成药的中药原料的重量配比为:
麝 香0.6g 冰 片4g 伸筋草4g
透骨草4g 夏枯草4g 风仙草4g
生川乌3g 生草乌3g 芒 硝9g
乌梅肉8g 生山楂肉8g 皂角刺4g
乳 香4g 没 药7g
制法:将上述药物分别炮炼、浓缩、加工细研,混合均匀,装入一个药袋即可。
实施例2,本发明中成药的中药原料的重量配比为:
麝 香0.3g 冰 片3g 伸筋草3g
透骨草3g 夏枯草3g 风仙草3g
生川乌2g 生草乌2g 芒 硝3g
乌梅肉5g 生山楂肉5g 皂角刺3g
乳 香3g 没 药3g
将上述重量配比的中药原料制成外用散剂中成药。
实施例3,本发明中成药的中药原料的重量配比为:
麝 香1g 冰 片5g 伸筋草5g
透骨草5g 夏枯草5g 风仙草5g
生川乌4g 生草乌4g 芒 硝15g
乌梅肉10g 生山楂肉10g 皂角刺5g
乳 香5g 没 药10g
将上述重量配比的中药原料制成外用散剂中成药。
Claims (2)
1、一种治疗骨质增生的中成药,其特征在于:本发明中成药的中药原料及重量配比为:
麝 香0.3-1份 冰 片3-5份 伸筋草3-5份
透骨草3-5份 夏枯草3-5份 风仙草3-5份
生川乌2-4份 生草乌2-4份 芒 硝3-15份
乌梅肉5-10份 生山楂肉5-10份 皂角刺3-5份
乳 香3-5份 没 药3-10份
将上述重量配比的中药原料制成外用散剂中成药。
2、根据权利要求1所述的治疗骨质增生的中成药,其特征在于:所述的中药原料的重量配比为:
麝 香0.6份 冰 片4份 伸筋草4份
透骨草4份 夏枯草4份 风仙草4份
生川乌3份 生草乌3份 芒 硝9份
乌梅肉8份 生山楂肉8份 皂角刺4份
乳 香4份 没 药7份
将上述重量配比的中药原料制成外用散剂中成药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01141086A CN1120014C (zh) | 2001-09-29 | 2001-09-29 | 一种治疗骨质增生的中成药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01141086A CN1120014C (zh) | 2001-09-29 | 2001-09-29 | 一种治疗骨质增生的中成药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1346673A CN1346673A (zh) | 2002-05-01 |
| CN1120014C true CN1120014C (zh) | 2003-09-03 |
Family
ID=4676050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN01141086A Expired - Fee Related CN1120014C (zh) | 2001-09-29 | 2001-09-29 | 一种治疗骨质增生的中成药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1120014C (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895480A (zh) * | 2012-11-07 | 2013-01-30 | 崔聪聪 | 一种治疗骨刺的中药 |
-
2001
- 2001-09-29 CN CN01141086A patent/CN1120014C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1346673A (zh) | 2002-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103006962A (zh) | 治疗骨质增生、腰椎间盘突出的外用中药液 | |
| CN101234153B (zh) | 治疗骨折的外用药物 | |
| CN103690623B (zh) | 一种跌打损伤药酒 | |
| CN101185672B (zh) | 一种内服用于治疗腰椎骨质增生的中药汤剂 | |
| CN1069527C (zh) | 一种治疗骨质增生、风寒湿痹的药物 | |
| CN1555857A (zh) | 用于治疗筋骨软组织损伤疼痛、骨折、脱臼药贴 | |
| CN102526482A (zh) | 一种治疗腰间盘突出的中药制剂 | |
| CN106985719A (zh) | 一种预防和治疗颈椎病的中药车枕 | |
| CN1120014C (zh) | 一种治疗骨质增生的中成药 | |
| CN1112206C (zh) | 接骨散 | |
| CN100534480C (zh) | 一种接骨药及其制作方法 | |
| CN1259065C (zh) | 一种快速接骨的中药制剂 | |
| CN104055973B (zh) | 治疗风湿骨病、关节疼痛的中药搽剂 | |
| CN1214813C (zh) | 一种治疗骨折的药物 | |
| CN1141955C (zh) | 一种治疗痹症的外用酊剂 | |
| CN104383175A (zh) | 一种用于治疗慢性骨髓炎的药物及制备方法 | |
| CN101954043A (zh) | 一种治疗骨质增生的药物及其制备方法 | |
| CN100531756C (zh) | 治疗骨病的外用中药 | |
| CN101297937B (zh) | 一种治疗颈椎病的中成药制剂及其制备方法 | |
| CN1115160C (zh) | 治疗骨质增生的口服药物 | |
| CN1209156C (zh) | 一种治疗陈旧伤复发痛的药酒 | |
| CN1224409C (zh) | 治疗腰间盘突出病症的药酒 | |
| CN117018108A (zh) | 一种高效缓解疼痛的药物组合物及其制备方法和其应用 | |
| CN114949145A (zh) | 消肿祛痛散及其制备方法 | |
| CN1308026C (zh) | 一种舒筋活络祛风除湿外用药酒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030903 Termination date: 20091029 |